Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
NATCO Announces Launch of the First Generic Version of Revlimid, in the U.S. market MD Bureau8 March 2022 2:50 PM ISTNATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene.
Biocon, Celgene settle patent litigation over cancer drug Revlimid Ruchika Sharma9 Sept 2021 2:58 PM ISTNew Delhi: Biotechnology major Biocon on Wednesday said it has entered into a settlement with Celgene Corporation regarding patents for Revlimid, a...
Natco Pharma arm launches first generic alternative to Revlimid in Canada Medical Dialogues Team2 Sept 2021 4:28 PM ISTNew Delhi: Natco Pharma (Canada), a subsidiary of Natco Pharma Limited, announced the launch of PrNat-Lenalidomide Capsules, the first generic...
Sun Pharma settles patent dispute with Celgene over generic Revlimid Ruchika Sharma22 Jun 2021 12:24 PM ISTMumbai: Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement...
Natco Pharma Lenalidomide Capsules secures USFDA okay Ruchika Sharma22 May 2021 12:58 PM ISTHyderabad: Pharma major, Natco Pharma Limited, announced the final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide ...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 4:36 PM ISTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
FDA approves Empliciti to treat multiple myeloma Meghna A Singhania3 Dec 2015 12:35 PM ISTToday the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with...
